2026-07-06T08:17:55Zhttps://repisalud.isciii.es/rest/oai/request

oai:repisalud.isciii.es:20.500.12105/275682026-06-27T00:17:55Zcom_20.500.12105_2052com_20.500.12105_2051col_20.500.12105_19609

00925njm 22002777a 4500 dc Codina Márquez, Helena author Quero-Delgado, Marta author Gómez, Rafael author Resino, Salvador author Martinez, Isidoro author Sepulveda-Crespo, Daniel author 2026-02-26 Dengue nanosensors promise much but have failed in clinical application. This paradox stems from a focus on record sensitivity over real-world robustness. We propose a paradigm shift from materials discovery to product engineering, providing a translational roadmap to guide viable diagnostics from the lab bench to the patient. Codina H, Quero-Delgado M, Gómez R, Resino S, Martínez I, Sepúlveda-Crespo D. Dengue nanosensors: a roadmap for clinical viability. Trends Biotechnol. 2026 Feb 26:S0167-7799(26)00005-3. doi: 10.1016/j.tibtech.2026.01.005. Epub ahead of print. PMID: 41760427. 10.1016/j.tibtech.2026.01.005 Trends in Biotechnology 41760427 https://hdl.handle.net/20.500.12105/27568 Clinical translation Dengue virus Nanosensors Point-of-care (PoC) diagnostics Sensor validation Dengue nanosensors: a roadmap for clinical viability.